ASCO20: Update on RAS-Mutated Sporadic Medullary Thyroid Cancer
COVID-19 and Head/Neck Cancer: International Consensus on Surgical Practice
ASCO20: Can Radioiodine Plus Durvalumab Improve Outcomes in Resistant Thyroid Cancer?
ASCO20: Outcomes in Subgroups of Patients With Medullary Thyroid Carcinoma Treated With Anlotinib
Mexican Study Focuses on Clinical Management of Pediatric Thyroid Cancer
Diagnosis of High-Suspicion Thyroid Nodules Using Elastography
Are Thyroglobulin Antibody Levels a Reliable Indicator of Thyroid Cancer Recurrence?
Role of Thyroglobulin in Detecting Recurrence of Thyroid Cancer After Surgery
Differentiated thyroid cancer (DTC): therapeutic updates and optimizing treatment
A Unique Approach to Assessing the Risk of Indeterminate Thyroid Nodules
Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma
Is Radioiodine Tx Overused in Low-Risk Thyroid Cancer?
University of Michigan Cancer Center
Cedars-Sinai Medical Center
University of California, San Francisco
Dabrafenib + Trametinib (Anaplastic Thyroid Cancer)
NCCN COVID-19 Resources Page
American Thyroid Association
Rogel Cancer Center Thyroid Cancer Patient Resources
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic